Displaying drugs 126 - 150 of 407 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Papain | Not Available |  | A proteolytic enzyme derived from papaya used for its anti-inflammatory properties. | Cysteine Endopeptidases / Papain, antagonists & inhibitors |
| Panitumumab | Not Available |  | A recombinant humanized monoclonal antibody used to treat EGFR-expressing, metastatic colorectal carcinoma that is refractory to fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens. | Antibodies, Monoclonal / EGFR (Epidermal Growth Factor Receptor) inhibitors |
| Pancrelipase protease | Not Available | | A lipase used to treat pancreatic exocrine insufficiency. | Hydrolases / Peptide Hydrolases |
| Pancrelipase lipase | 48000.0 |  | A lipase used to treat pancreatic exocrine insufficiency. | Carboxylic Ester Hydrolases / Lipase |
| Pancrelipase amylase | 57086.0 |  | A lipase used to treat pancreatic exocrine insufficiency. | Amylases / Amylases, antagonists & inhibitors / Glycoside Hydrolases |
| Pancrelipase | 131000.0 | | A purified form of porcine pancreatic lipase, amylase, and protease enzymes used to treat malabsorption associated with pancreatic insufficiency resulting from cystic fibrosis and pancreatitis. | Enzyme Preparations |
| Palivizumab | Not Available |  | A monoclonal anti respiratory syncytial virus F protein antibody used to prevent serious sequelae caused by respiratory syncytial virus infection in pediatric patients. | Antiviral monoclonal antibodies / Specific Immunoglobulins |
| Palifermin | 16192.7 C721H1142N202O204S9 |  | A form of recombinant human keratinocyte growth factor used to prevent and treat oral mucositis following radiation or chemotherapy. | Detoxifying Agents for Antineoplastic Treatment |
| Oxytocin | 1007.187 C43H66N12O12S2 |  | A recombinant hormone used to induce or strengthen uterine contractions in pregnant women to aid in labor and delivery or to control postpartum bleeding. | Oxytocin and Analogues |
| Oprelvekin | 19047.2 C854H1411N253O235S2 |  | A form of recombinant interleukin-11 used to stimulate production of megakaryocytes and platelets in patients with or at risk of thrombocytopenia after chemotherapy. | Interleukins |
| Omalizumab | 149000.0 |  | A monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy. | Anti-Allergic Agents / Anti-Asthmatic Agents / Anti-IgE / Antibodies, Monoclonal, Humanized |
| Olipudase alfa | 63590.933 C2900H4373N783O791S24 | | A recombinant human acid sphingomyelinase used to treat Acid Sphingomyelinase Deficiency (ASMD) in children and adults. | Alimentary Tract and Metabolism / Amino Acids, Peptides, and Proteins / Enzyme Replacement Therapy / Enzymes / Enzymes and Coenzymes / Esterases / Hydrolases / Phosphoric Diester Hydrolases / Proteins / Recombinant Proteins |
| Olaratumab | 154000.0 C6554H10076N1736O2048S40 | | A platelet-derived growth factor receptor alpha blocking antibody used with doxorubicin to treat patients with certain types of soft tissue sarcoma (STS). | Antibodies, Monoclonal |
| Ofatumumab | 146100.0 C6480H10022N1742O2020S44 |  | An anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. | Antibodies, Monoclonal / CD20 (Clusters of Differentiation 20) inhibitors / Selective Immunosuppressants |
| Odesivimab | 146164.54 C6506H10024N1720O2030S42 | | Part of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus. Together, these three antibodies act to neutralize viral particles and to recruit immune effectors for the destruction of both viral particles and infected cells. | Antiviral Agents |
| Octreotide | Not Available | | A peptide drug used to treat acromegaly as well as diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide secreting tumors. | Antineoplastic Agents, Hormonal / Gastrointestinal Agents / Peptides, Cyclic / Somatostatin and Analogues |
| Ocriplasmin | 27250.0 C1214H1890N338O348S14 | | A proteolytic enzyme used to treat symptomatic vitreomacular adhesion by dissolving the protein matrix responsible for the adhesion between the vitreous and macula. | Peptide Hydrolases |
| Ocrelizumab | 145000.0 C6494H9978N1718O2014S46 | | A CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis. | Selective Immunosuppressants |
| Obinutuzumab | 146100.0 C6512H10060N1712O2020S44 |  | An antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil. | Antibodies, Monoclonal / CD20 (Clusters of Differentiation 20) inhibitors |
| Obiltoxaximab | 148000.0 | | A monoclonal antibody used for prophylaxis or treatment of inhalational anthrax. | Antibacterial monoclonal antibodies / Specific Immunoglobulins |
| Nogapendekin alfa | 12770.45 | | An IL-15 receptor agonist used to treat BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours. | Receptors, Interleukin-15 |
| Nivolumab | 143597.3811 C6362H9862N1712O1995S42 |  | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. | Antibodies, Monoclonal / PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Nirsevimab | 146300.0 C6494H10060N1708O2050S46 | | A long-acting monoclonal antibody indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants. | Antiviral monoclonal antibodies |
| Neuropeptide Y | Not Annotated | | Neuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus. | Neuropeptide Y, drug effects / Neuropeptides |
| Nesiritide | 3464.0 |  | A recombinant natriuretic peptide used for the treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity. | Natriuretic Agents / Natriuretic Peptide, Brain / Natriuretic Peptides / Nerve Tissue Proteins |
Displaying drugs 126 - 150 of 407 in total